A lawsuit was filed on behalf of investors in DENTSPLY SIRONA Inc. (NASDAQ: XRAY) shares over alleged securities laws violations.
San Diego, CA -- (SBWIRE) -- 01/14/2019 -- An investor, who purchased shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY), filed a lawsuit over alleged violations of Federal Securities Laws by DENTSPLY SIRONA Inc.
Investors in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) have certain options and for certain investors are short and strict deadlines running. Deadline: February 19, 2019. NASDAQ: XRAY investors should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The plaintiff claims that between February 20, 2014 through August 7, 2018, the Defendants attributed the Company's financial performance to the Company's "innovation," "operational improvement efforts," "new products," and "continued investments in sales and marketing" and told investors that these factors helped the Company succeed despite the "highly competitive" market for its products. In reality, the Company's financial results had been buoyed by an anticompetitive scheme among the Company's three primary distributors that suppressed competition in the dental supply market and artificially inflated the price of dental supplies sold by Dentsply. Further, Defendants concealed that an exclusive distribution arrangement that Sirona had with one of its distributors, Patterson Companies, Inc. ("Patterson"), required Patterson to regularly make large minimum purchases regardless of demand and, as a result, by 2015, Patterson had been supplied with so much excess inventory that it could not be sold. This channel-stuffing rendered the Company's reported sales, financial results and guidance materially false and misleading. In addition, the Company represented that it reported its financial statements, including its goodwill, in accordance with generally accepted accounting principles, or GAAP. In reality, the Company's reported goodwill was artificially inflated and not reported in accordance with GAAP because it did not reflect the financial impact of the anticompetitive scheme.
The plaintiff says that the truth about DENTSPLY SIRONA's financial condition and business was revealed in a series of corrective disclosures. Specifically, the plaintiff claims that in a series of disclosures culminating on August 7, 2018, DENTSPLY SIRONA Inc disclosed that it was subject of an investigation by the Securities and Exchange Commission, announced the surprise departure of the Company's top three executives, repeatedly downwardly revised its guidance, and reported several quarters of disappointing financial results and significant goodwill impairment charges that were attributed to, among other things, an "increase in competition" and destocking from the Company's dealer partners, including Patterson.
Those who purchased shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels